Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.31 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7115814 | 0.87 | HSD17B10 (0.36) | HSD17B10OPRD1P2RY6 | |
| SCHEMBL6560883 | 0.84 | HSD17B10 (0.30) | HSD17B10 | |
| SCHEMBL1743117 | 0.78 | HSD17B10 (0.43) | HSD17B10OPRD1P2RY6 | |
| SCHEMBL29402282 | 0.78 | HSD17B10 (0.43) | HSD17B10OPRD1P2RY6 | |
| SCHEMBL141450 | 0.76 | HSD17B10 (0.39) | HSD17B10OPRD1P2RY6 | |
| SCHEMBL6757638 | 0.76 | HSD17B10 (0.39) | HSD17B10OPRD1P2RY6 | |
| SCHEMBL6550277 | 0.76 | HSD17B10 (0.39) | HSD17B10OPRD1P2RY6 | |
| SCHEMBL12847616 | 0.74 | HSD17B10 (0.38) | HSD17B10OPRD1P2RY6 | |
| SCHEMBL9429585 | 0.74 | HSD17B10 (0.39) | HSD17B10OPRD1P2RY6 | |
| SCHEMBL6560873 | 0.74 | HSD17B10 (0.34) | HSD17B10OPRD1P2RY6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1397339-A1 | (ETHYLENE)-(PROPYLENE)-TRIAMINEPENTAACETIC ACID DERIVATIVES, PROCESS FOR THEIR PRODUCTION, AND THEIR USE FOR THE PRODUCTION OF PHARMACEUTICAL AGENTS | Schering Aktiengesellschaft (DE) | 2004-03-17 | — | — | EP | disclosed |
| WO-2003000647-A1 | (ETHYLENE)-(PROPYLENE)-TRIAMINEPENTAACETIC ACID DERIVATIVES, PROCESS FOR THEIR PRODUCTION, AND THEIR USE FOR THE PRODUCTION OF PHARMACEUTICAL AGENTS | SCHERING AG (DE) | 2003-01-03 | — | — | WO | disclosed |